Mosaic brain: a new test for childhood epilepsy
Part of Brain & nervous system clinical trials.
This study tests a new way to understand epilepsy in children by looking at the brain's 'mosaic' (mixed) makeup using samples from a lumbar puncture (spinal tap). It aims to help children who are already being evaluated for epilepsy surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child must be under 18 years old.
- They must be in the epilepsy surgery program at Great Ormond Street Hospital (GOSH), with a clear or suspected brain lesion seen on MRI.
- They may also qualify if they are scheduled for a type of brain test called SEEG (stereo-electroencephalography).
- They must be able to safely have a lumbar puncture (a spinal tap) before surgery.
- Children with a malignant (cancerous) brain tumor or those being treated for an ischemic lesion (stroke-like damage) are not eligible.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a safe brain scan (MEG) to help doctors plan epilepsy surgery for children. It aims to make surgery safer and more precise by mapping key brain areas beforehand.
This trial uses advanced brain imaging to map the networks causing seizures in children with certain types of epilepsy. The goal is to better understand where seizures start so doctors can plan more targeted treatments.
This trial uses a new, more detailed DNA test (long-read sequencing) to find the cause of severe epilepsy with developmental delays in children when standard genetic testing did not provide an answer. It aims to help families understand the genetic basis of their child's condition.
This study uses a special, detailed brain-mapping technique (called high-resolution electrical source imaging) to see how well it can predict success after epilepsy surgery in children. It aims to help doctors decide which children might benefit most from surgery.
This trial tests a new type of brain scanner (MEG) to help locate the exact area in the brain causing seizures in people with drug-resistant epilepsy. The goal is to improve planning for surgery to remove that area.
This study uses special MRI pictures to better plan epilepsy surgery and help lower the chance of new brain problems after surgery. It includes children and teens with drug-resistant focal epilepsy who are having a two-stage surgery with brain surface electrodes.
Hear when a new Epilepsy Intractable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.